Efficacy of a Novel Affitoxin Targeting Major Outer Membrane Protein Against Chlamydia trachomatis In Vitro and In Vivo
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiae257 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Mingyang Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical Universi…. Hauptthemen laut MEDLINE: Chlamydia trachomatis, Chlamydia Infections, Bacterial Outer Membrane Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Wenzhou Municipal Science and Technology Bureau Program, Wenzhou Medical University Scientific Research and Development Fund.
Abstract (Originalsprache)
Targeted therapy is an attractive approach for treating infectious diseases. Affibody molecules have similar capability to antibodies that facilitate molecular recognition in both diagnostic and therapeutic applications. Targeting major outer membrane protein (MOMP) for treating infection of Chlamydia trachomatis, one of the most common sexually transmitted pathogens, is a promising therapeutic approach. Previously, we have reported a MOMP-specific affibody (ZMOMP:461) from phage display library. Here, we first fused it with modified Pseudomonas exotoxin (PE38KDEL) and a cell-penetrating peptide (CPP) to develop an affitoxin, Z461X-CPP. We then verified the addition of both toxin and CPPs that did not affect the affinitive capability of ZMOMP:461 to MOMP. Upon uptake by C trachomatis–infected cells, Z461X-CPP induced cell apoptosis in vitro. In an animal model, Z461X significantly shortened the duration of C trachomatis infection and prevented pathological damage in the mouse reproductive system. These findings provide compelling evidence that the MOMP-specific affitoxin has great potential for targeting therapy of C trachomatis infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Zhejiang, China.
ORCID-Profile: Mingyang Li
Förderung
- National Nature Science Foundation of China
- Wenzhou Municipal Science and Technology Bureau Program
- Wenzhou Medical University Scientific Research and Development Fund
- Project
Zitieren
APA
Li, M., Yang, J., Zhou, L., Zhang, J., Li, Y., Chen, J., Dong, H., Zhang, L., & Zhu, S. (2024). Efficacy of a Novel Affitoxin Targeting Major Outer Membrane Protein Against Chlamydia trachomatis In Vitro and In Vivo. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae257
Vancouver
Li M, Yang J, Zhou L, Zhang J, Li Y, Chen J, et al. Efficacy of a Novel Affitoxin Targeting Major Outer Membrane Protein Against Chlamydia trachomatis In Vitro and In Vivo. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae257
BibTeX
@article{Li2024,
author = {Li, Mingyang and Yang, Jia and Zhou, Luqi and Zhang, Jing and Li, Yang and Chen, Jun and Dong, Haiyan and Zhang, Lifang and Zhu, Shanli},
title = {Efficacy of a Novel Affitoxin Targeting Major Outer Membrane Protein Against Chlamydia trachomatis In Vitro and In Vivo},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiae257}
}
EUVIMED